Tango Therapeutics Inc. held its annual meeting of stockholders on June 5, 2025. During the meeting, Lesley Ann Calhoun was elected to the Board of Directors. Stockholders ratified the selection of PricewaterhouseCoopers, LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025. An amendment to the company's certificate of incorporation to increase the number of authorized shares of common stock from 200,000,000 to 400,000,000 was approved.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.